BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dammen-brower K, Epler P, Zhu S, Bernstein ZJ, Stabach PR, Braddock DT, Spangler JB, Yarema KJ. Strategies for Glycoengineering Therapeutic Proteins. Front Chem 2022;10:863118. [DOI: 10.3389/fchem.2022.863118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Park S, Chin-Hun Kuo J, Reesink HL, Paszek MJ. Recombinant mucin biotechnology and engineering. Adv Drug Deliv Rev 2023;193:114618. [PMID: 36375719 DOI: 10.1016/j.addr.2022.114618] [Reference Citation Analysis]
2 Chen B, Liu W, Li Y, Ma B, Shang S, Tan Z. Impact of N-Linked Glycosylation on Therapeutic Proteins. Molecules 2022;27. [PMID: 36557993 DOI: 10.3390/molecules27248859] [Reference Citation Analysis]
3 Mccraw AJ, Gardner RA, Davies AM, Spencer DIR, Grandits M, Wagner GK, Mcdonnell JM, Karagiannis SN, Chenoweth A, Crescioli S. Generation and Characterization of Native and Sialic Acid-Deficient IgE. IJMS 2022;23:13455. [DOI: 10.3390/ijms232113455] [Reference Citation Analysis]
4 Sheikh MO, Capicciotti CJ, Olivier-van Stichelen S. Editorial: Glycotherapeutics: Design, synthesis, function and biomedical application of agents emerging from glycochemistry and glycobiology. Front Mol Biosci 2022;9:1012485. [DOI: 10.3389/fmolb.2022.1012485] [Reference Citation Analysis]